Sai Life Sciences Limited reports robust quarterly results
Revenue grows by 15%; Net Profit up 36% year-on-year Hyderabad, February 7, 2025: Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused,
Revenue grows by 15%; Net Profit up 36% year-on-year Hyderabad, February 7, 2025: Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused,
Guwahati, Assam, India, July 27, 2024 – Glenmark Foundation announces a strategic partnership with the Centre for North East Studies & Policy Research (C-NES) and
Q1FY2025 Performance Highlights Revenues at ₹10,875m, Grew 16.7% YoY in line with FY25 Outlook Gross Margin improved by 264bps YoY to 61.3% EBITDA grew by
Expert in battery testing further strengthens H.E.L’s expertise in thermal safety Professor Duh will be delivering two seminars on behalf of H.E.L Group on
Exterior AD Gen ambulance Interior AD Gen Ambulance eeting India’s Needs for Affordable, High-Quality Medical Transportation Solutions Pinnacle Industries, India’s leading automotive interiors, seating, and
VDMA Valves and Messe Düsseldorf agree to collaborate on the world’s leading valve trade fair, VALVE WORLD EXPO. Frankfurt, July 11, 2024 – The VDMA
AOI Gurugram organised Health talk organised in Ashiana Nirmai, a senior residential complex AOI Calicut CME Named Head Neck Cancer concepts and-updates Conducted In Association
Mumbai, June 28, 2024: Today Fortis Hospital Mulund proudly announced the launch of its state-of-the-art ‘Sports Injury Clinic’ setting a new standard in advanced care
Mumbai, 28 June 2023: Indian Pharmaceutical Alliance (IPA) today successfully concluded the 9th edition of the Global Pharmaceutical Quality Summit 2024. The theme for the Summit
Mumbai, 20th June 2024: Plasmagen Biosciences Private Limited (“Plasmagen”), the Indian biopharmaceutical organization, headquartered in Bengaluru, specializing exclusively in Plasma Protein and Speciality Care Therapy, has recently
Hyderabad, June 7, 2024: Gland Pharma Limited (BSE: 543245 I NSE: GLAND), a generic injectable-focused pharmaceutical company, today announced that Srinivas Sadu, the incumbent Managing